STAT

Opinion: Bioethicists worried patients couldn’t handle their own genetic testing results. They were (mostly) wrong

The psychosocial impacts of receiving genetic information are more complex than imagined at the dawn of the Human Genome Project. Patients and consumers need help to understand and deal with…

When the Human Genome Project began in 1990, bioethicists feared that giving people the results of genetic tests would do them a lot more harm than good.

Experts feared that individuals who received genetic information about their future health status would be overwhelmed by depression or anxiety. Or as genetic testing became more widely available, it would increase the stigmatization of people with genetic variants. Others worried that people would turn into genetic essentialists and determinists, seeing themselves and others as nothing more than their genes, helpless to alter their behavior or shape their future.

Those concerns . The first major on the effect of disclosing genetic information found that people who decided to for people who, after a process of informed consent, decided they wanted to receive information about single genes associated with Huntington’s disease and breast and ovarian cancer.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks